2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow SP-420: new trials by email Literature Review of SP-420 trials Research Report on SP-420
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety of SP-420 in the Treatment of Transfusional Iron Overload SP-420 - Iron Overload | Phase 1 | Terminated | The University of Texas Health Science Center at San Antonio | 2 | 2021-03-09 | 2024-12-27 |
| Safety and Pharmacokinetic Study of Escalating Doses of SP-420, an Iron Chelator, in Patients With β-Thalassemia SP-420 - Iron Overload, Beta-Thalassemia | Phase 1 | Terminated | Sideris Pharmaceuticals | 24 | 2014-10-01 | 2015-09-29 |
Iron Overload (2) · Thalassemia (1) · beta-Thalassemia (1)
Sideris Pharmaceuticals (1) · The University of Texas Health Science Center at San Antonio (1)
United States (2) · Canada (1) · Lebanon (1) · Thailand (1) · Turkey (Türkiye) (1)
Supreet Kaur, MD (1)